113 related articles for article (PubMed ID: 27967655)
1. Encapsulation of Adenovirus BMP2-Transduced Cells with PEGDA Hydrogels Allows Bone Formation in the Presence of Immune Response.
Alvarez-Urena P; Davis E; Sonnet C; Henslee G; Gugala Z; Strecker EV; Linscheid LJ; Cuchiara M; West J; Davis A; Olmsted-Davis E
Tissue Eng Part A; 2017 Mar; 23(5-6):177-184. PubMed ID: 27967655
[TBL] [Abstract][Full Text] [Related]
2. Endochondral bone formation from hydrogel carriers loaded with BMP2-transduced cells.
Bikram M; Fouletier-Dilling C; Hipp JA; Gannon F; Davis AR; Olmsted-Davis EA; West JL
Ann Biomed Eng; 2007 May; 35(5):796-807. PubMed ID: 17340196
[TBL] [Abstract][Full Text] [Related]
3. Hydrogel microsphere encapsulation of a cell-based gene therapy system increases cell survival of injected cells, transgene expression, and bone volume in a model of heterotopic ossification.
Olabisi RM; Lazard ZW; Franco CL; Hall MA; Kwon SK; Sevick-Muraca EM; Hipp JA; Davis AR; Olmsted-Davis EA; West JL
Tissue Eng Part A; 2010 Dec; 16(12):3727-36. PubMed ID: 20673027
[TBL] [Abstract][Full Text] [Related]
4. Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type.
Gugala Z; Olmsted-Davis EA; Gannon FH; Lindsey RW; Davis AR
Gene Ther; 2003 Aug; 10(16):1289-96. PubMed ID: 12883525
[TBL] [Abstract][Full Text] [Related]
5. Development of a Cell-Based Gene Therapy Approach to Selectively Turn Off Bone Formation.
Alvarez-Urena P; Zhu B; Henslee G; Sonnet C; Davis E; Sevick-Muraca E; Davis A; Olmsted-Davis E
J Cell Biochem; 2017 Nov; 118(11):3627-3634. PubMed ID: 28621436
[TBL] [Abstract][Full Text] [Related]
6. Use of a chimeric adenovirus vector enhances BMP2 production and bone formation.
Olmsted-Davis EA; Gugala Z; Gannon FH; Yotnda P; McAlhany RE; Lindsey RW; Davis AR
Hum Gene Ther; 2002 Jul; 13(11):1337-47. PubMed ID: 12162816
[TBL] [Abstract][Full Text] [Related]
7. [The feasibility of adenoviral co-transduction of BMP2 and BMP7 for the expression of recombinant human BMP2/7 heterodimer in rat bone marrow mesenchymal stem cells].
Gao T; Tang S; Niu C; Miao C; Zhang W; Zhou L; Wu C; Liu F
Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Mar; 32(2):125-29. PubMed ID: 30024692
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus BMP2-induced osteogenesis in combination with collagen carriers.
Gugala Z; Davis AR; Fouletier-Dilling CM; Gannon FH; Lindsey RW; Olmsted-Davis EA
Biomaterials; 2007 Oct; 28(30):4469-79. PubMed ID: 17645942
[TBL] [Abstract][Full Text] [Related]
9. Rapid healing of femoral defects in rats with low dose sustained BMP2 expression from PEGDA hydrogel microspheres.
Sonnet C; Simpson CL; Olabisi RM; Sullivan K; Lazard Z; Gugala Z; Peroni JF; Weh JM; Davis AR; West JL; Olmsted-Davis EA
J Orthop Res; 2013 Oct; 31(10):1597-604. PubMed ID: 23832813
[TBL] [Abstract][Full Text] [Related]
10. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model.
Zhu W; Rawlins BA; Boachie-Adjei O; Myers ER; Arimizu J; Choi E; Lieberman JR; Crystal RG; Hidaka C
J Bone Miner Res; 2004 Dec; 19(12):2021-32. PubMed ID: 15537446
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of stiffness-tunable and cell-responsive Gelatin-poly(ethylene glycol) hydrogel for three-dimensional cell encapsulation.
Cao Y; Lee BH; Peled HB; Venkatraman SS
J Biomed Mater Res A; 2016 Oct; 104(10):2401-11. PubMed ID: 27170015
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7.
Zhao M; Zhao Z; Koh JT; Jin T; Franceschi RT
J Cell Biochem; 2005 May; 95(1):1-16. PubMed ID: 15759283
[TBL] [Abstract][Full Text] [Related]
13. Development of a biostable replacement for PEGDA hydrogels.
Browning MB; Cosgriff-Hernandez E
Biomacromolecules; 2012 Mar; 13(3):779-86. PubMed ID: 22324325
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene.
Cheng SL; Lou J; Wright NM; Lai CF; Avioli LV; Riew KD
Calcif Tissue Int; 2001 Feb; 68(2):87-94. PubMed ID: 11310352
[TBL] [Abstract][Full Text] [Related]
15. Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice.
Coates PT; Krishnan R; Kireta S; Johnston J; Russ GR
Gene Ther; 2001 Aug; 8(16):1224-33. PubMed ID: 11509955
[TBL] [Abstract][Full Text] [Related]
16. The effect of polymer molecular weight and cell seeding density on viability of cells entrapped within PEGDA hydrogel microspheres.
Perera D; Medini M; Seethamraju D; Falkowski R; White K; Olabisi RM
J Microencapsul; 2018 Aug; 35(5):475-481. PubMed ID: 30280941
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of In Vivo Osteogenic Potential of Bone Morphogenetic Protein 2-Overexpressing Human Periodontal Ligament Stem Cells Combined with Biphasic Calcium Phosphate Block Scaffolds in a Critical-Size Bone Defect Model.
Yi T; Jun CM; Kim SJ; Yun JH
Tissue Eng Part A; 2016 Mar; 22(5-6):501-12. PubMed ID: 26825430
[TBL] [Abstract][Full Text] [Related]
18. Cholesteryl group- and acryloyl group-bearing pullulan nanogel to deliver BMP2 and FGF18 for bone tissue engineering.
Fujioka-Kobayashi M; Ota MS; Shimoda A; Nakahama K; Akiyoshi K; Miyamoto Y; Iseki S
Biomaterials; 2012 Oct; 33(30):7613-20. PubMed ID: 22800537
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of dermal fibroblast-mediated and direct adenoviral bone morphogenetic protein-2 gene therapy for bone regeneration in an equine rib model.
Ishihara A; Zekas LJ; Weisbrode SE; Bertone AL
Gene Ther; 2010 Jun; 17(6):733-44. PubMed ID: 20220786
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein 2 gene transduction enhances the osteogenic potential of human urine-derived stem cells.
Guan J; Zhang J; Zhu Z; Niu X; Guo S; Wang Y; Zhang C
Stem Cell Res Ther; 2015 Jan; 6(1):5. PubMed ID: 25567327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
